PharmaShots | Incisive News in 3 Shots

Subscribe Now

Shanghai Biomabs Pharmaceutical

Shanghai Biomabs Pharmaceutical Reports P-III Study Results of CMAB008 (biosimilar, infliximab) for Rheumatoid Arthritis

Shanghai Biomabs Pharmaceutical Reports P-III Study Results of CMAB008 (biosimilar, infliximab) for Rheumatoid Arthritis

August 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us